The Appeal and Impact of E-cigarettes in Smokers With SMI

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

January 31, 2021

Conditions
Tobacco DependenceSchizophreniaBipolar DisorderSchizoaffective Disorder
Interventions
BEHAVIORAL

E-cigarette

The e-cigarette arm will be provided with 8 weeks of free e-cigarettes based on self-report of regular tobacco use. Participants assigned in this arm will be asked to switch combustible tobacco with e-cigarettes. The appeal of e-cigarettes and health impacts will be measured, but we are not targeting quitting combustible tobacco or reducing craving.

Trial Locations (2)

40211

Centerstone Kentucky, Louisville

01843

Vinfen Corp, Lawrence

All Listed Sponsors
collaborator

Vinfen

INDUSTRY

collaborator

Centerstone Kentucky

UNKNOWN

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT03050853 - The Appeal and Impact of E-cigarettes in Smokers With SMI | Biotech Hunter | Biotech Hunter